(MSD) Welcomes News That Pharmac Is Proposing To Fund KEYTRUDA® (pembrolizumab) For 5 Additional Cancer Types 0 05.07.2024 19:49 Scoop Merck Sharp & Dohme (New Zealand) Limited (MSD) welcomes news that Pharmac is consulting on a funding proposal for KEYTRUDA® (pembrolizumab) for five additional types of cancer. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
